SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/28/12 Ziopharm Oncology Inc 10-Q/A 6/30/12 50:3.1M Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 10-Q/A Amendment to Quarterly Report HTML 29K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 20K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 20K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 18K 32: R1 Document and Entity Information HTML 37K 23: R2 Balance Sheets HTML 112K 30: R3 Balance Sheets (Parenthetical) HTML 39K 34: R4 Statements Of Operations HTML 67K 46: R5 Statement Of Stockholders' Equity HTML 66K 24: R6 Statement Of Stockholders' Equity (Parenthetical) HTML 18K 29: R7 Statements of Cash Flows HTML 142K 21: R8 Business HTML 26K 15: R9 Summary of Significant Accounting Policies HTML 19K 47: R10 Collaborations and Alliances HTML 21K 36: R11 Fair Value Measurements HTML 38K 35: R12 Net Loss per Share HTML 23K 40: R13 Related Party Transactions HTML 22K 41: R14 Commitments and Contingencies HTML 53K 39: R15 Warrants HTML 52K 42: R16 Common Stock HTML 19K 31: R17 Stock-Based Compensation HTML 48K 33: R18 Fair Value Measurements (Tables) HTML 27K 38: R19 Net Loss per Share (Tables) HTML 22K 50: R20 Warrants (Tables) HTML 42K 44: R21 Stock-Based Compensation (Tables) HTML 52K 26: R22 Business - Additional Information (Detail) HTML 23K 37: R23 Collaborations and Alliances - Additional HTML 24K Information (Detail) 28: R24 Assets and Liabilities Measured at Fair Value on HTML 26K Recurring Basis (Detail) 13: R25 Potential Dilutive Shares Excluded from HTML 26K Computation of Diluted Net Loss Per Share (Detail) 45: R26 Related Party Transactions - Additional HTML 28K Information (Detail) 48: R27 Commitments and Contingencies - Additional HTML 121K Information (Detail) 18: R28 Number of Warrants Outstanding (Detail) HTML 21K 17: R29 Warrants - Additional Information (Detail) HTML 74K 19: R30 Assumptions Used In Binomial Valuation Model and HTML 25K Black-Scholes Valuation Model (Detail) 20: R31 Warrant Exercise (Detail) HTML 32K 22: R32 Common Stock - Additional Information (Detail) HTML 34K 11: R33 Stock-Based Compensation Expense on All Employee HTML 23K and Non-Employee Awards (Detail) 43: R34 Stock-Based Compensation - Additional Information HTML 31K (Detail) 25: R35 Fair Value of Stock Options Assumptions Using HTML 34K Black-Scholes Option Valuation Model (Detail) 27: R36 Stock Option Activity Under Stock Option Plan HTML 83K (Detail) 14: R37 Summary of Unvested Restricted Stock (Detail) HTML 46K 49: XML IDEA XML File -- Filing Summary XML 74K 16: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 392K 5: EX-101.INS XBRL Instance -- ziop-20120630 XML 731K 7: EX-101.CAL XBRL Calculations -- ziop-20120630_cal XML 109K 8: EX-101.DEF XBRL Definitions -- ziop-20120630_def XML 650K 9: EX-101.LAB XBRL Labels -- ziop-20120630_lab XML 966K 10: EX-101.PRE XBRL Presentations -- ziop-20120630_pre XML 726K 6: EX-101.SCH XBRL Schema -- ziop-20120630 XSD 147K 12: ZIP XBRL Zipped Folder -- 0001144204-12-048414-xbrl Zip 101K
Download this zipped .zip folder. | |
Files: | ziop-20120630.xml ziop-20120630_cal.xml ziop-20120630_def.xml ziop-20120630_lab.xml ziop-20120630_pre.xml ziop-20120630.xsd |